Activity Title | Activity Type | Start Date | End Date | Member(s) | |
---|---|---|---|---|---|
Roche Young Scientist Award (RYSA) Competition 2017 | Pro-bono (Unpaid) Project for Non-academic Organization | 2016-09-12 | 2017-05-21 | Cheng Pat-leung Victor Lau Kwok-leung LO Yuk-ming Dennis | |
'Public Health' themed lecture on "Hepatitis A, B, C, D, E and more" | Public Event (Delivering a Talk, Workshop, Exhibition, Performance, etc.) | 2013-11-13 | 2013-11-13 | ||
Seminar on Viral Hepatitis for Nurses and Allied Health Professionals 2014 | Public Event (Delivering a Talk, Workshop, Exhibition, Performance, etc.) | 2014-05-15 | 2014-05-15 | ||
Public Seminar on Hepatitis B and Other Viral Hepatitis | Public Event (Delivering a Talk, Workshop, Exhibition, Performance, etc.) | 2014-06-27 | 2014-06-27 | ||
RTHK Radio 2 Programme "知識會社" | Books and Other Media (Newspaper, Radio/TV, etc.) for Non-academic Audiences | 2015-05-23 | 2015-05-23 | ||
The 728 HKHEPBFREE Dinner Seminar on the World Hepatitis Day | Public Event (Delivering a Talk, Workshop, Exhibition, Performance, etc.) | 2014-07-28 | 2014-07-28 | ||
Health Exhibition by Medical Society, HKUSU | Public Event (Delivering a Talk, Workshop, Exhibition, Performance, etc.) | 2014-10-18 | 2014-10-18 | ||
第2屆翡翠絲帶社責計劃之 "肝癌與肝炎專題講座" | Public Event (Delivering a Talk, Workshop, Exhibition, Performance, etc.) | 2014-08-04 | 2014-08-04 | ||
Seminar on Viral Hepatitis for Nurses and Allied Health Professionals 2015 | Public Event (Delivering a Talk, Workshop, Exhibition, Performance, etc.) | 2015-05-14 | 2015-05-14 | ||
Public seminar on "Hepatitis B and Other Hepatitis" | Public Event (Delivering a Talk, Workshop, Exhibition, Performance, etc.) | 2015-06-27 | 2015-06-27 | ||
Roche Young Scientist Award Competition | Pro-bono (Unpaid) Project for Non-academic Organization | 2014-09-17 | 2015-05-07 | ||
Public seminar on "乙型及其他肝炎" | Public Event (Delivering a Talk, Workshop, Exhibition, Performance, etc.) | 2016-03-13 | 2016-03-13 | ||
肝炎與肝癌專題講座 | Public Event (Delivering a Talk, Workshop, Exhibition, Performance, etc.) | 2015-07-13 | 2015-07-13 | ||
Public seminar on "乙型及其他肝炎" | Public Event (Delivering a Talk, Workshop, Exhibition, Performance, etc.) | 2015-07-19 | 2015-07-19 | ||
Seminar on Viral Hepatitis for Nurses and Allied Health Professionals 2016 | Public Event (Delivering a Talk, Workshop, Exhibition, Performance, etc.) | 2016-05-12 | 2016-05-12 | ||
Public seminar on "肝炎與肝癌" | Public Event (Delivering a Talk, Workshop, Exhibition, Performance, etc.) | 2015-07-22 | 2015-07-22 | ||
Public seminar on 乙型及其他肝炎 | Public Event (Delivering a Talk, Workshop, Exhibition, Performance, etc.) | 2015-07-02 | 2015-07-02 | ||
Seminar on Hepatitis B | Public Event (Delivering a Talk, Workshop, Exhibition, Performance, etc.) | 2016-05-20 | 2016-05-20 | ||
肝炎與肝癌專題講座 - 擊退乙肝 | Public Event (Delivering a Talk, Workshop, Exhibition, Performance, etc.) | 2017-06-03 | 2017-06-03 | ||
Seminar on Viral Hepatitis for Nurses and Allied Health Professionals | Public Event (Delivering a Talk, Workshop, Exhibition, Performance, etc.) | 2017-06-01 | 2017-06-01 | ||
Planning Meeting - A 100-Day Campaign "Toward a Hepatitis-Free Hong Kong" | Other KE Activity Types | 2019-06-26 | 2019-06-26 | ||
Health talk | Public Event (Delivering a Talk, Workshop, Exhibition, Performance, etc.) | 2018-07-10 | 2018-07-10 | ||
Special article for World Hepatitis Day 2019 | Books and Other Media (Newspaper, Radio/TV, etc.) for Non-academic Audiences | 2019-05-29 | 2019-05-29 | ||
Group member of opinion leaders for a planning meeting for Hep-Free Asia Summit 2019 | Other KE Activity Types | 2019-04-17 | 2019-04-17 | ||
Story on the treatement of hepatitis B | Books and Other Media (Newspaper, Radio/TV, etc.) for Non-academic Audiences | 2019-01-04 | 2019-01-04 | ||
北角西分區委員會健康講座 | Public Event (Delivering a Talk, Workshop, Exhibition, Performance, etc.) | 2019-01-13 | 2019-01-13 | ||
Invited talk on「肝炎預防及治療」at 九龍婦女聯會活動 | Public Event (Delivering a Talk, Workshop, Exhibition, Performance, etc.) | 2019-03-31 | 2019-03-31 | ||
Seminar on Viral Hepatitis for Nurses and Allied Health Professionals 2019 | Public Event (Delivering a Talk, Workshop, Exhibition, Performance, etc.) | 2019-06-04 | 2019-06-04 | ||
世界肝炎日「關心關愛攜手共抗乙肝」活動 | Public Event (Delivering a Talk, Workshop, Exhibition, Performance, etc.) | 2018-07-28 | 2018-07-28 | ||
Hepatitis B: A Time Bomb on The Pearl Report (on air date: 16 Oct 2017) | Books and Other Media (Newspaper, Radio/TV, etc.) for Non-academic Audiences | 2017-10-16 | 2017-10-16 | ||
Roundtable Discussion: Campaign for Hepatitis Free Hong Kong | Pro-bono (Unpaid) Project for Non-academic Organization | 2018-03-22 | 2018-03-22 | Hong Kong Hep B Free Foundation | |
An Update on HBV Treatment | Public Event (Delivering a Talk, Workshop, Exhibition, Performance, etc.) | 2017-11-24 | 2017-11-24 | ||
都是乙肝惹的禍《新聞透視》- on air date: 16 Sep 2017 | Books and Other Media (Newspaper, Radio/TV, etc.) for Non-academic Audiences | 2017-09-16 | 2017-09-16 | ||
北角西分區委員會健康講座 - 主講 "肝炎與肝癌" | Public Event (Delivering a Talk, Workshop, Exhibition, Performance, etc.) | 2018-01-13 | 2018-01-13 | ||
Health Seminar | Public Event (Delivering a Talk, Workshop, Exhibition, Performance, etc.) | 2018-01-20 | 2018-01-20 | ||
Special Funding for Impact Evidence Collection: KE-SR-2017/18-2: Impact Evidence Collection for Units of Assessment in the Li Ka Shing Faculty of Medicine (HK$1,700,000) | KE Project Grant | 2018-03-20 | 2019-06-30 | Liu Chi Leung Lam Ka Wai Katherine | |
翡翠絲帶擊退乙肝晚會 | Public Event (Delivering a Talk, Workshop, Exhibition, Performance, etc.) | 2019-07-13 | 2019-07-13 |
Title | Conference | Date |
---|---|---|
Physical Examination of the Abdomen | 2022 GI Review for Licensing Examination, Hong Kong, 17 October 2022 | 2022-10-01 |
Hepatitis Diseases - The major causes of HCC | Lecture and Discussion Session for Roche Healthcare Professional, Hong Kong, 12 November 2021 | 2021-11-01 |
Hepatitis Prevention and Treatment 2021 | World Hepatitis Day Event: Jade Ribbon Fights Back Hepatitis B 2021 Campaign. Hong Kong Hep B Free Foundation Ltd., Hong Kong, 11 July 2021 | 2021-07-01 |
Richard Yu Lecture. Viral Epidemics: Hepatitis B, Hepatitis C and COVID-19 | The 25th Hong Kong Medical Forum, Department of Medicine, The University of Hong Kong, 15-16 May | 2021-05-01 |
Keynote Lecture: “Clinical Research v.s. Silient Epidemics: Resilience in the Race against Time” | Harvard College in Asia Program ((HCAP) - Hong Kong Conference, Hong Kong, 21 March | 2021-03-01 |
Keynote Lecture "Frontiers of Medicine" | Virtual International Student Medical Forum 2021, Asklepian Medical Society, St. Paul's Co-educational College, Hong Kong, 30 January | 2021-01-01 |
HBV vs HCV | HCV Macau Dinner Symposium, Macao Society of Gastroenterology and Hepatology, Macau, 26 November | 2019-11-01 |
HCV elimination in Asia”, Roundtable 1 - “HCV is curable: What is the best HCV testing algorithm to support HCV elimination programs? | Pre-International Roche Infectious Diseases (IRIDS 2018), Vienna, Austria, 4 September | 2019-09-01 |
Hepatitis A-E | 20190713 香港乙肝基金會 - 翡翠絲帶擊退乙肝晚會, Hong Kong, 13 Jul | 2019-07-01 |
Reducing the risks when treating patients with Chronic Hepatitis B | Round Table Discussion under the Auspices of Gastroenterological Society of Singapore and supported by an educational grant from Gilead Sciences, 6 June 2019, Singapore. | 2019-06-01 |
Hepatitis B and C | Seminar on Viral Hepatitis for Nurses and Allied Health Professionals 2019, Special Preventive Programme Viral Hepatitis Control Office, Central for Health Protection, Jun 4, 2019, Hong Kong | 2019-06-01 |
Should Antenatal Antiviral Medication be Given for Hepatitis B Carriers? | The Obstetrical and Gynaecological Society of Hong Kong Annual Scientific Meeting 2019, Hong Kong Academy of Medicine Jockey Club Building, 1-2 June 2019, Hong Kong. | 2019-06-01 |
Global & Regional Epidemiology of HCV: Pathways to Its Elimination by 2030 | Plenary Session 1: Global Perspectives, KDIGO CUHK HCV Implementation Summit (Town Hall Meeting), Prince of Wales Hospital, 1 June 2019, Hong Kong. | 2019-06-01 |
Overview of Chronic hepatitis B Infection | Alice Ho Miu Ling Nethersole Hospital Medical and Healthcare professionals on 24 May 2019, Hong Kong. | 2019-05-01 |
Overview of Chronic hepatitis B Infection | Tseung Kwan O Hospital Medical and Healthcare professionals on 29 May 2019, Hong Kong. | 2019-05-01 |
Hepatitits A-E | Jointly organized by Hep B Free Foundation & the Hong Kong Federation of Women on March 31, 2019, MacPherson Stadium, Kowloon, Hong Kong. | 2019-03-01 |
Overview of Chronic hepatitis B Infection | Queen Elizabeth Hospital Medical and Healthcare professionals on 21 March 2019, Hong Kong. | 2019-03-01 |
Overview of Chronic Hepatitis B Infection | Tuen Mun Hospital Medical Meeting, January 11, 2019, Hong Kong | 2019-01-01 |
Overview of Chronic Hepatitis B Infection | Pamela Youde Nethersole Eastern Hospital, January 21, 2019, Hong Kong. | 2019-01-01 |
Introduction of James Gibson Lecture | Symposium II: Genetics & Genomics, HK Pathology Forum 2019, January 26, 2019, Hong Kong. | 2019-01-01 |
Two Patients with Cirrhosis of the Liver | Macau Society of Clinical Internal Medicine, January 27, 2019, Macau | 2019-01-01 |
Overview of Chronic Hepatitis B Infection | Hong Kong Sanatorium & Hospital Ltd. Breakfast Meeting, December 11, 2018, Hong Kong, | 2018-12-01 |
Patients with Chronic Hepatitis B (CHB) on Immunosuppression | Joint Annual Scientific Meeting 2018 of the Hong Kong College of Dermatologists and the Hong Kong Society of Paediatric Dermatology, November 4, 2018, Hong Kong. | 2018-11-01 |
Clinical Decisions for CHB Treatment | APASL Single Topic Conference 2018, December 6-8, 2018, Beijing, China. | 2018-11-01 |
Across borders: The challenge of HBV & HCV with increasing globalization | The Hong Kong Association for the Study of Liver Diseases 31~^st~~ Annual Scientific Meeting and Intenational Symposium on Hepatology 2018, Hong Kong | 2018-11-01 |
Overview of Chronic Hepatitis B Infection | Pok Hoi Hospital Medical Meeting, November 30, 2018, Hong Kong. | 2018-11-01 |
Patients with Chronic Hepatitis B (CHB) on Immunosuppression | Baptitis Hospital, October 25, 2018, Hong Kong. | 2018-10-01 |
Chronic Hepatitis C in 2018”, Annual Scientific Meeting 2018 - Medical Advances for Community Health | The Federation of Medical Societies of Hong Kong (FMSHK), October 7, 2018, Hong Kong, | 2018-10-01 |
Updates on Hepatitis C Infection | The 10~^th~~ Macau Forum of Hospital Medicine, and 2018 Annual Scientific Meeting of Macau Physician Association of Public Hospital, October 7, 2018, Macau. | 2018-10-01 |
Across borders: The challenge of HBV and HCV in the setting of increasing globalization | 2018 International Roche Infectious Diseases (IRIDS 2018), Sepember 24-26, 2018, Vienna, Austria. | 2018-09-01 |
HCV in 2018 EASL Data and Recent Updates | Princess Margaret Hospital Medical Grand Round | 2018-09-01 |
Overview of Chronic Hepatitis B Infection | Northern District Hospital | 2018-09-01 |
HCV in 2018”, EASL Debrief 2018 | Queen Elizabeth Hospital, Kowloon, Hong Kong, August 6, 2018 | 2018-08-01 |
Updates on HCV management | Scientific Dinner Symposium of Macao Society of Gastroenterology and Hepatology (MSGEH), Macau, August 29, 2018 | 2018-08-01 |
Patients with Chronic Hepatitis B (CHB) on Immunosuppression | Chronic Hepatitis B Round Table Meeting with Oncologists, Hong Kong Integrated Oncology Centre, Hong Kong, August 14, 2018 | 2018-08-01 |
Hepatitis and Liver Cancer | Public Health Seminar on World Hepatitis Day 2018, jointly organized by Sai Kung District Council and Hong Kong Hep B Free Foundation, Tseung Kwan O, Hong Kong, July 28, 2018 | 2018-07-01 |
Cultivating One’s Self: M, J, MJ, M | Medical Summer Broadening Programme, LKS Faculty of Medicine, The University of Hong Kong, July 23, 2018 | 2018-07-01 |
Hepatitits B | Health Talk organized by St Paul’s Convent School, Causeway Bay, Hong Kong, July 10, 2018 | 2018-07-01 |
Practical Guidelines for the Treatment of Patients with Chronic Hepatitis B (CHB) on Immunosuppression | IL-17 Summit, Greater Bay Area Psoriasis Treatment Summit 2018, Macau, April 28-29 | 2018-04-01 |
Practical Guidelines for the Treatment of Patients with Chronic Hepatitis B (CHB) on Immunosuppression | IL-17 Summit, Greater Bay Area Psoriasis Treatment Summit 2018, Macau, April 28-29, 2018 | 2018-04-01 |
Hepatitis | Health Seminar for Fire Services Department, NT Command Headquarters, at the Auditorium of Ma On Shan Paramedic Training Centre, Hong Kong, January 20, 2018 | 2018-01-01 |
(399) “認識肝炎 | 北角西分區委員會健康講座, jointly organized by北角西分區委員會 and 香港乙肝基金會 , at銅鑼灣社區中心三樓禮堂, Hong Kong, January 13 | 2018-01-01 |
認識肝炎 | 北角西分區委員會健康講座, jointly organized by北角西分區委員會 and 香港乙肝基金會 , at銅鑼灣社區中心三樓禮堂, Hong Kong, January 13, 2018 | 2018-01-01 |
Hepatitis | Health Seminar for Fire Services Department, NT Command Headquarters, at the Auditorium of Ma On Shan Paramedic Training Centre, Hong Kong, January 20 | 2018-01-01 |
Case Discussion: An unusual case of hepatitis reactivation | Symposium 2017, State Key Laboratory for Liver Research, The University of Hong Kong, Hong Kong | 2017-11-01 |
An Update on HBV Treatment | University Health Service, The University of Hong Kong, Hong Kong, November 24 | 2017-11-01 |
An Update on HBV Treatment | University Health Service, The University of Hong Kong, Hong Kong, November 24, 2017 | 2017-11-01 |
Update on Chronic Hepatitis C Studies | AbbVie Scientific Meeting, Hong Kong, November 28 | 2017-11-01 |
Update on Chronic Hepatitis C Studies | AbbVie Scientific Meeting, Hong Kong, November 28, 2017 | 2017-11-01 |
Chronic Hepatitis B: HBsAg Seroclearance, cccDNA and Treatment under Trial | JGHF Okuda Lecturership, Asian Pacific Digestive Week 2017 (APDW 2017), Hong Kong, September 24, 2017. | 2017-09-01 |
Pan Genotypic Approach to HCV Cure | Gilead APDW Scientific Symposium, Asian Pacific Digestive Week 2017 (APDW 2017), Hong Kong, September 25, 2017 | 2017-09-01 |
Update on Hepatitis B Treatment | Hepatitis B Symposium organized by the Society of Hospital Pharmacists of Hong Kong, 21 July 2017, Hong Kong | 2017-07-01 |
擊退乙肝 | 肝炎與肝癌專題講座, 香港乙肝基金會 (Hong Kong Hep B Free Foundation), 3 June 2017, 歐陽均諾議員辦事處及何華漢議員辦事處協辨, 九龍灣佛教慈敬學校 | 2017-06-01 |
Treatment of Chronic Hepatitis B | Seminar on Viral Hepatitis for Nurses and Allied Health Professionals, Department of Health, Centre for Health Protection, 1 June 2017, Hong Kong | 2017-06-01 |
Update on Chronic Hepatitis C Studies | Round-table Dinner Discussion, 10 May 2017, Hong Kong | 2017-05-01 |
Occult HBV | Concurrent Session: Viral Hepatitis and Co-Infection, the 26th Conference of the Asian Pacific Association for the Study of the Liver (APASL), 15-19 February 2017, Shanghai, China | 2017-02-01 |
Update on Chronic Hepatitis C Studies | Infection Control Association of Macao Scientific Meeting, 24 Feb 2017, Macau | 2017-02-01 |
Sofosbuvir/Velpatasvir for 12 weeks results in high SVR12 rates with a favorable safety profile in Asian patients: an integrated subgroup analysis of the ASTRAL-1, ASTRAL-2, and ASTRAL-3 studies | Hepatology International ISSN: 1936-0533 ; eISSN: 1936-0541 | 2017-02-01 |
Update on HCV Management | Hong Kong Medical Journal ISSN: 1024-2708 ; eISSN: 2226-8707 | 2017-01-01 |
Optimizing HCV management: the role of ribavirin | Symposium on Leading Change in Hepatitis C, 8 September 2016, Hong Kong, | 2016-09-01 |
Practical guidance on treating chronic hepatitis B virus infection: real-life cases from my patients | IL‐17 Summit, Hong Kong, 27 August 2016, Hong Kong | 2016-08-01 |
Treatment to eradicate Hepatitis B- is there light at the end of the tunnel? | Symposium 4 - Viral Hepatitis, GUT 2016 – Annual Scientific Meeting of Malaysian Society of Gastroenterology & Hepatology (MSGH), 22-24 July 2016, Kuala Lumpur, Malaysia | 2016-07-01 |
Simplifying hepatitis C treatment - Myth or reality? | Satellite Symposium, GUT 2016 – Annual Scientific Meeting of Malaysian Society of Gastroenterology & Hepatology (MSGH), 22-24 July 2016, Kuala Lumpur, Malaysia | 2016-07-01 |
Chronic Hepatitis C | Asia Pacific AIDS & Co-infections Conference 2016 (APACC 2016), Hong Kong Exhibition & Convention Centre, Hong Kong, May 17-19 | 2016-05-01 |
Treating Chronic Hepatitis B in 2015 | Seminar on Viral Hepatitis for Nurses and Allied Health Professionals 2015, Department of Health, Hong Kong, May 12 | 2016-05-01 |
Hepatitis B | Seminar for Department of Chemical Pathology of the Chinese University of Hong Kong”, Hong Kong, 20~^th~~ May | 2016-05-01 |
乙型及其他肝炎 | Public seminar jointly organized by the Hong Kong Hep B Free Foundation, 富息居民服務社 and 宏逸居民服務社, Hong Kong, 13~^th~~ March | 2016-03-01 |
Challenges and Opportunities in the Management of Chronic Hepatitis B Infection | Plenary Lecture at the 17~^th~~ International Congress on Infectious Diseases, Hyderabad, India, March 2-5 | 2016-03-01 |
Transforming your mind”, Medical Humanities Year 2 Conversations and Connections | Guest Lecture Series, Medical Ethics and Humanities Unit, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, March 22 | 2016-03-01 |
Latest developments of chronic hepatitis C treatment | Joint Scientific Meeting in Chronic Hepatitis C Management co-organized by Macao Society of Gastroenterology & Hepatology and Infection Control Association of Macao, Macau, 9~^th~~ December | 2015-12-01 |
Reduction of cccDNA with long-term nucleos/tide analogue treatment in chronic hepatitis | 28~^th~~ Annual Scientific Meeting of the Hong Kong Association for the Study of Liver Diseases, Hong Kong, 22~^nd~~ November | 2015-11-01 |
Case Discussion: a patient with severe abdominal distension following TCM ingestion | State Key Laboratory for Liver Research (SKLLR) Symposium 2015, Hong Kong, 17~^th~~ October | 2015-10-01 |
Getting to know Viekira Pak | Meet the Expert Dinner Symposium, Hong Kong, 22~^nd~~ October | 2015-10-01 |
Hepatitis B and Other Hepatitis | Health Exhibition organized by Medical Society, HKUSU, Ma On Shan Plaza, Shatin, Hong Kong,18~^th ~~ October | 2015-10-01 |
HBV viral load versus HBsAg seroclearance versus reduction of cccDNA as endpoint of treatment | Sanofi-Union Hospital HBV Symposium, Wuhan, China, 12~^th~~ September | 2015-09-01 |
Review and update on the role of NAs in the prevention of mother to child transmission | Cross Strait China, Hong Kong and Taiwan Chronic Hepatitis B Forum, Chengdu, China, 8~^th~~ August | 2015-08-01 |
Real World Long-term Experience of CHB Management | 8~^th~~ Annual Scientific Symposium of the Infection Control Association of Macao (ICAM), 4~^th~~ July | 2015-07-01 |
乙型及其他肝炎 | Public Seminar jointly organized by Hong Kong Hep B Free Foundation and Kowloon Lok Sin Tong, Hong Kong, 2~^nd~~ July | 2015-07-01 |
乙型及其他肝炎 | Public Seminar jointly organized by the Hong Kong Hep B Free Foundation and 香港廣東社團總會 - 新界東辦事處及民建聯沙田支, Shatin, Hong Kong,19~^th~~ July | 2015-07-01 |
乙型及其他肝炎 | Public Seminar jointly organized by the Hong Kong Hep B Free Foundation and 深水埗區議會, 深水埗大坑東社區中心, Kowloon, Hong Kong, 22~^th~~ July | 2015-07-01 |
乙型及其他肝炎 | Public seminar jointly organized by the Hong Kong Hep B Free Foundation and Eastern District Council, Causeway Bay Community Centre, Hong Kong, June 27, 2015 | 2015-06-01 |
Real World Long-Term Experience of CHB Management | Baraclude Sponsored Scientific Symposium entitled ‘Chronic Hepatitis B Updates in Asia Pacific - From Clinical Evidence to Real Life Patient Setting: What's New & What to Expect’, Kuala Lumper, Malaysia, May 16, 2015 | 2015-05-01 |
Treating Chronic Hepatitis B in 2015 | Seminar on Viral Hepatitis for Nurses and Allied Health Professionals 2015, Department of Health, Hong Kong, May 14, 2015 | 2015-05-01 |
Effect of Nucleoside Analogues on Fibrosis, Hepatocellular Carcinoma and cccDNA in Chronic Hepatitis B | Asian Oncology Summit, 11~^th~~ Annual Conference of the Organisation for Oncology and Translational Research and Viral Hepatitis Summit 2015, Shanghai, China, Apr 10-12, 2015 | 2015-04-01 |
Turning Point in Chronic Hepatitis C | Joint Scientific Meeting in Chronic Hepatitis C Management jointly organized by Macao Society of Gastroenterology and Hepatology & Infection Control Association of Macao, Macau, March 6, 2015 | 2015-03-01 |
Transforming Your Minds: M, J, MJ, M | Medical Humanities Guest Speaker Series “Conversations and Connections Year 2, Medical Ethics and Humanities Unit, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, February 10, 2015 | 2015-02-01 |
Treatment Endpoints for CHB | The 4~^th~~ HBV Single Topic Conference, Asian Pacific Association for the Study of the Liver (APASL), Guangzhou, China, December 12-14, 2014 | 2014-12-01 |
Key Considerations in Long-term Treatment Journey – Safety Surveillance and Management | The 4~^th~~ HBV Single Topic Conference, Asian Pacific Association for the Study of the Liver (APASL), Guangzhou, China, December 12-14, 2014 | 2014-12-01 |
Interferon vs Nucleos/tide Analogues in Chronic Hepatitis B | The 3~^rd~~ international Hepatology Conference organized by the Hepatology Society, Dhaka, Bangladesh, November 20-21, 2014. | 2014-11-01 |
乙型及其他肝炎 | Seminar organized by the Hong Kong Hep B Free Foundation for the employees of Shangri-La, Hong Kong, August 4 | 2014-08-04 |
Hepatitis & you | 728 HKHEPBFREE Dinner Seminar on the World Hepatitis Day, Hong Kong, July 28 | 2014-07-28 |
乙型及其他肝炎 | Public seminar organized by the Hong Kong Hep B Free Foundation, Hong Kong, June 27 | 2014-06-27 |
Turning points in CHC care: how fast are things changing? | The Liver Week 2014, the 20~^th~~ Annual Meeting of the Korean Association for the Study of the Liver (KASL) & Postgraduate Course, Jeju Island, Korea, June 12-14 | 2014-06-12 |
The treatment of chronic hepatitis B: The past, the present and the future | 302 Beijing Hospital Meeting, Beijing, China, May 20 | 2014-05-20 |
Long-term management of CHB: the ultimate endpoints | 8~^th~~ HBV-Focus (第八届聚焦乙肝論坛), Chinese Hospital Association, Beijing, China, May 17 | 2014-05-17 |
Treatment of chronic hepatitis B | Seminar on Viral Hepatitis for Nurses and Allied Health Professionals 2014, Centre of Health Protection, Department of Health, Hong Kong, May 15 | 2014-05-15 |
HCV epidemiology and unmet needs across the APAC region | Gilead HCV symposium ' Transforming HCV care across the Asia-Pacific region' during the Asian Pacific Association for The Study of the Liver (APASL) 2014, Brisbane, Australia, March 12 | 2014-03-12 |
Transforming your mind | Medical Humanities Guest Speaker Series – Year One “Conversations and Connections”, Medical Ethics and Humanities Unit, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, February 18 | 2014-02-18 |
Duration/endpoints of treatment | Expert Panel Meeting: Recommendations for the management of chronic hepatitis B infection, organized by Department of Medicine, The University of Hong Kong, Cyberport, Hong Kong, December 7-8 | 2013-12-07 |
Future therapy | Expert Panel Meeting: Recommendations for the management of chronic hepatitis B infection, organized by Department of Medicine, The University of Hong Kong, Cyberport, Hong Kong, December 7-8 | 2013-12-07 |
Debate: Immune tolerant patients: To treat or not to treat? | Session 2: Current HBV Issues in Asia, 3~^rd~~ Asia Hepatology Perspectives Forum, Busan, Korea, November 29-30 | 2013-11-29 |
Long term efficacy and safety of nucleoside analogues | Special Symposium: Optimizing treatment outcomes in hepatitis, 3~^rd~~ APASL (Asian Pacific Association for the Study of the Liver) HCC (Hepatocellular Carcinoma) Conference with the concept, HCC in 3D: Dimension, Detection, Decision, Cebu City, Philippines, November 21-23 | 2013-11-23 |
Role of Antivirals in HBV-related HCC | Symposium 1: Risk Factors and Prevention of HCC in Asia Pacific, 3~^rd~~ APASL (Asian Pacific Association for the Study of the Liver) HCC (Hepatocellular Carcinoma) Conference with the concept, HCC in 3D: Dimension, Detection, Decision, Cebu City, Philippines, November 21-23 | 2013-11-22 |
Hepatitis A, B, C, D, E and more | Wah Yan College, Kowloon, with a theme 'Public Health', Hong Kong, November 13 | 2013-11-13 |
Hepatitis C Virus: Pegylated interferon (pegIFN) ~!a2a vs ~!a2b | GASTRO 2013 APDW/WOCG, Shanghai, China, September 21 – 24 | 2013-09-22 |
Antiviral Treatment: Are We Achieving our Goal? | HKASLD Expert Standalone Meeting 'Chronic hepatitis B management: learning from around the Asia region', Hong Kong, July 20 | 2013-07-20 |
New Treatment of Chronic Hepatitis C | 澳門公立醫院醫生協會 | 2013-06-23 |
"HBV Treatment: Past, Present and Future", ~/State-of-the-Art Lecture~~ | 23~^rd~~ Conference of the Asian Pacific Association for the Study of the Liver (APASL 2013), Singapore, June 8 | 2013-06-08 |
"Exploring the Virologic/Serologic Response", ~/Gilead Satellite Symposium 'Where do we go from here? Exploring HBV treatment endpoints'~~ | 23~^rd~~ Conference of the Asian Pacific Association for the Study of the Liver (APASL 2013), Singapore, June 8 | 2013-06-08 |
"Response Guided Therapy – Nucleoside", ~/Clinical Track Session: Personalized Treatment of HBV~~ | 23~^rd~~ Conference of the Asian Pacific Association for the Study of the Liver (APASL 2013), Singapore, June 7 | 2013-06-07 |
Treatment of Hepatitis B in 2013 | Seminar on Viral Hepatitis for Nurses and Allied Health Professionals 2013, Centre of Health Protection, Department of Health, Hong Kong, May 16 | 2013-05-16 |
HCV in Hong Kong | Victrelis Launch Meeting, Hong Kong, May 14 | 2013-05-14 |
"Optimizing Recent HCV Treatments and Exploring Future’s Paradigm", ~/Symposium Chairman~~ | The 18~^th~~ Hong Kong Medical Forum, Department of Medicine, The University of Hong Kong, Hong Kong, May 11 | 2013-05-11 |
Discussion on Hong Kong Consensus Guidelines for the Treatment of Chronic Hepatitis C | The Third Hepatitis C Expert Input Forum, Hong Kong, April 13 | 2013-04-13 |
"The Hepatitis B Virus and I”, ~/Special Honorary Fellow Award Lecture~~ | The 32~^nd~~ Annual General Meeting cum Scientific Meeting, The Hong Kong Society of Gastroenterology, March 14 | 2013-03-14 |
Viread-Real-Life experiences from Clinical Practices | Viread Scientific Symposium in Seoul, South Korea, February 26-27 | 2013-02-26 |
Long Term Real World Data from Clinical Trials to Practice | Hepatology Society of the Philippines Annual Symposium, Manila, Philippines, January 25-26 | 2013-01-26 |
Debate: Treatment of Chronic Hepatitis B. Why I use of interferon? versus Why I use nucleos(t)ide analogues | Hepatology Society of the Philippines Annual Symposium, Manila, Philippines, January 25-26, | 2013-01-25 |
"Significance of HCV in Asia Pacific region", ~/Co-chair the luncheon symposium~~ | The Asian Pacific Digestive Week (APDW) 2012, Bangkok, Thailand between December 5-8 | 2012-12-07 |
Boceprevir Hong Kong case presentation | Hepatitis C Expert Input Forum 2012, Hong Kong, November 24 | 2012-11-24 |
Epidemiology of HBsAg-negative HBV carriers (Occult HBV) | APASL 3rd Single Topic Conference (STC) on Hepatitis B Virus, Dhaka, Bangladesh between October 6-7 | 2012-10-07 |
Prevention of HCC by antiviral treatment | The First Central China International Forum on Liver Disease and Infection (CCIFLDI) hosted by Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China between September 21-23 | 2012-09-23 |
"The present and future treatment of chronic hepatitis C", ~/Keynote Lecture~~ | Symposium 2012 State Key Laboratory for Liver Research (SKLLR), The University of Hong Kong, Hong Kong, September 22 | 2012-09-22 |
Reduction of hepatitis B surface antigen and?covalently closed circular DNA by?nucleoside/nucleotide analogues of different potency | State Key Laboratory for Liver Research Symposium 2012, HKU | 2012-09-01 |
Plenary lecture entitled "Treating hepatitis B in 2012" | International Journal of Infectious Diseases ISSN: 1201-9712 ; eISSN: 1878-3511 | 2012-06-15 |
Current Therapy of Chronic Hepatitis B | 2~^nd~~ Wave B-Bridge in China, Chengdu and Shenyang, China, between May 29 & 30 | 2012-05-29 |
The Acronym Quartet: CHB, cccDNA, OHB & HCC | Grand Round Research Meeting, Department of Medicine, The University of Hong Kong, Hong Kong, 26~^th~~ May | 2012-05-26 |
Current Therapy of Chronic Hepatitis B | B-Focus in China organized by Chinese Journal of Infectious Diseases, Guangzhou, China, 19~^th~~-20~^th~~ May | 2012-05-20 |
When can we stop anti-viral agents for chronic hepatitis B? | 17~^th~~ Hong Kong Medical Forum, Hong Kong, 12~^th~~-13~^th~~ May | 2012-05-13 |
Resistance Considerations in CHB Management | Gilead Post-EASL Regional Advisory Programs, in San Francisco, Costa Mesa, Los Angeles, and New York, USA between May 5-19, 2012 | 2012-05-05 |
Management of HBV in patients on immunosuppressants | Multi-specialty Medical Mega Conference 2.0, Hong Kong, 14~^th~~-15~^th~~ April | 2012-04-14 |
Current therapy of chronic hepatitis B: nucleos/tide analogues and drug resistance | Baraclude High 5 Symposium, Korea, 26~^th~~-28~^th~~ March | 2012-03-27 |
New and future treatment for chronic hepatitis C | Infection Control Association of Macao, Macau, 16~^th~~ March | 2012-03-16 |
Making headway – long-term Asian data from clinical trials and clinical practice | 22~^nd~~ Conference of the Asian Pacific Association for the Study of the Liver (APASL 2012), BMS Sponsored Satellite Symposium, Taipei, Taiwan, 16~^th~~-19~^th~~ February | 2012-02-18 |
Current therapy of chronic hepatitis B – nucleos(t)ide analogues and drug resistance | 22~^nd~~ Conference of the Asian Pacific Association for the Study of the Liver (APASL 2012), Plenary Lecture and Postgraduate Course, Taipei, Taiwan, 16~^th~~-19~^th~~ February | 2012-02-16 |
Recent controversies in the management of hepatitis B patients | MSGEH Expert Meeting, Macau, 13~^th~~ January | 2012-01-13 |
Co-chairperson of the Welcome & Overview: Day 1 Review Program Agenda and Objectives | MSD Asia Pacific HCV Speakers’ Forum: Evolving Concepts in HCV Therapy, 10~^th~~-11~^th~~ December | 2011-12-11 |
The future development in hepatology | 30~^th~~ Anniversary Scientific Meeting of the Hong Kong Society of Gastroenterology, Hong Kong, 9~^th~~ December | 2011-12-09 |
What treatment outcomes could lead to stopping antiviral therapy in CHB? | Asia Hepatology Perspectives Forum – Long-term treatment and disease outcomes in chronic hepatitis B, Hong Kong, 26~^th~~-27~^th~~ November | 2011-11-27 |
The etiology of ‘cryptogenic’ hepatocellular carcinoma | International Symposium on Hepatology 2011, 24~^th~~ Annual Scientific Meeting, The Hong Kong Association for the Study of Liver Diseases, Hong Kong, 20~^th~~ November | 2011-11-20 |
Prevention of hepatocellular carcinoma: HBV vaccination and anti-viral therapy | State Key Laboratory for Liver Research (SKLLR) Symposium, The University of Hong Kong, Hong Kong, 24~^th~~ September | 2011-09-24 |
HBV vaccination and antiviral therapy | Fifth International Liver Cancer Association (ILCA) Annual Conference, Hong Kong, 2~^nd~~-4~^th~~ September | 2011-09-02 |
Genetic Analysis of Occult Hepatitis B Virus Infection | State Key Laboratory for Liver Research Symposium, 2011, HKU. | 2011-09-01 |
HKASLD Expert Meeting: Trouble-free management of hepatitis B patients, Hong Kong, July 5 | HKASLD Expert Meeting: Trouble-free management of hepatitis B patients, Hong Kong, July 5 | 2011-07-05 |
The long-term management of CHB patients – insights obtained from special population | HKASLD Expert Meeting: Trouble-free management of hepatitis B patients, Hong Kong, 5~^th~~ July | 2011-07-05 |
Durability of HBeAg Seroconversion | Gilead Medical Affairs Advisory Program entitled ‘When to Stop Therapy in Chronic Hepatitis B’, San Francisco, USA, June 16-17 | 2011-06-16 |
Optimal treatment of chronic hepatitis B with long-term therapy | Seminar on Viral Hepatitis for Nurses, Centre for Health Protection, Hong Kong Central Library, Hong Kong, May 19 | 2011-05-19 |
The evolving strategies in drug resistance management | GSK CHB evening symposium, Hong Kong, April 28 | 2011-04-28 |
Baraclude Asian cohort efficacy, resistance and histology data and Hong Kong 4 years real life data | BMS Symposium ‘Hepatitis B treatment: a closer look at Asian patients’, Seoul, Gwangju, Daejeon and Incheon, Korea, April 19-23 | 2011-04-19 |
Optimal treatment of chronic hepatitis B with long-term therapy | Post APASL/EASL Symposium, Kaohsiung, Taiwan, April 16 | 2011-04-16 |
An update of chronic hepatitis B treatment guidelines | Tenofovir Disoproxil Fumarate Launch Symposium "A New Era for the Treatment of Chronic Hepatitis B", Hong Kong, March 22 | 2011-03-22 |
Optimal management in 2011 and beyond | BMS Satellite Symposium "Future prospects in the progression of liver disease from viral hepatitis to hepatocellular carcinoma" at the 21~^st~~ International Conference of the Asian Pacific Association for Studies of the Liver (APASL), Bangkok, Thailand, Feb 17-20 | 2011-02-19 |
The evolving future of hepatitis B treatment: latest thinking and emerging practice | Gilead Satellite Symposium 'Enlightening the Future' at the 21~^st~~ International Conference of the Asian Pacific Association for Studies of the Liver (APASL), Bangkok, Thailand, Feb 17-20 | 2011-02-19 |
Drug-resistant mutants – the Achilles heel of therapy: management and newer anti-virals in pipeline | 3~^rd~~ Kolkata Liver Meeting, Kolkata, India, December 3-5 | 2010-12-04 |
A critical review of the treatment guidelines of chronic hepatitis B | 3~^rd~~ Kolkata Liver Meeting, Kolkata, India, December 3-5 | 2010-12-03 |
The third first line agent | International Symposium on Hepatology 2010, The Hong Kong Association for the Study of Liver Diseases, Hong Kong, November 21 | 2010-11-21 |
An update on hepatitis B and its current management | Seminar of Infection Control Association of Macao, Macau, October 15 | 2010-10-15 |
State-of-the-Art Lecture entitled "Management of Chronic Hepatitis B Infection". | Falk Symposium – Gut and Liver, Beijing, China, August 27-28 | 2010-08-28 |
Management of Chronic Hepatitis B Infection | State-of-the-Art Lecture, Falk Symposium – Gut and Liver, Beijing, China, August 27-28, 2010 | 2010-08-28 |
Immunosuppression and Reactivation of Chronic Hepatitis B | 14~^th~~ Congress of Asia Pacific League of Associations for Rheumatology (APLAR 2010), Hong Kong, July 11-15, 2010 | 2010-07-13 |
乙型肝炎 | Hepatitis B Public Education Outreach Program, The Hong Kong Liver Foundation , Hong Kong, May 16, 2010 | 2010-05-16 |
Management of Chronic Hepatitis B | Seminar on Viral Hepatitis for Nurses 2010, Department of Health, Hong Kong, May 13, 2010 | 2010-05-13 |
Management of Chronic Hepatitis B | 15~^th~~ Hong Kong Medical Forum. Faculty of Medicine, The University of Hong Kong, Hong Kong, May 8-9, 2010 | 2010-05-08 |
Duration of Therapy for Chronic Hepatitis B | GSK Evening Symposium, Hong Kong, April 29, 2010. | 2010-04-29 |
Monitoring and Minimizing Resistance to Antiviral Therapy in Chronic Hepatitis B | 20~^th~~ Conference of the Asian Pacific Association for the Study of the Liver (APASL), Beijing, China, March 26, 2010 | 2010-03-26 |
Antiviral Therapy for Chronic Hepatitis B: Resistance, Fibrosis, Clinical Trials with Entecavir | Symposium of Infection Control Association of Macao, Macau, January 8, 2010 | 2010-01-08 |
Antiviral Therapy for Chronic Hepatitis B: Resistance, Fibrosis, Clinical Trials with Entecavir | Scientific Meeting – From durable viral suppression to disease regression, Hong Kong Association for the Study of Liver Diseases and Hong Kong Medical Association, Hong Kong, November 26, 2009 | 2009-11-26 |
Occult hepatitis B Infection: Incidence, Detection and Clinical Implications | Plenary Session: TTI, the XX~^th~~ Regional Congress of the International Society of Blood Transfusion (ISBT), Asia, Nagoya, Japan, November 17, 2009 | 2009-11-17 |
Occult Hepatitis B Infection: Incidence, Detection and Clinical Implications | International Symposium on Hepatology 2009/22~^nd~~ Annual Scientific Meeting of the Hong Kong Association for the Study of Liver Diseases in Hong Kong, November 8, 2009 | 2009-11-08 |
Risk Estimation for Hepatocellular Carcinoma in Chronic Hepatitis B Patient | 16~^th~~ Hong Kong International Cancer Congress/6~^th~~ Annual Meeting of Cetnre for Cancer Research, Centre for Cancer Research, Li Ka Shing Faculty of Medicine, The University of Hong Kong, November 4-6, 2009 | 2009-11-06 |
Reinventing Chronic Hepatitis B in Canada | Gilead Sciences Canada Inc., Vancouver, Toronto and Montreal, Canada, October 2-6, 2009 | 2009-10-02 |
Chronic Hepatitis B: Natural History, Treatment Guidelines and Treatment Options – Focus: Asian-Pacific Region | AiCuris GmbH & Co. KG, Wuppertal, Germany, August 14, 2009 | 2009-08-14 |
Long term data for oral anti virals in CHB treatment | Bristol-Myers Squibb Round-table Meeting, Hong Kong on June 19 | 2009-06-19 |
Management of primary non-response and resistance to antiviral therapy for chronic hepatitis B | 12~^th~~ Annual Meeting of the British Infection Society held at School of Oriental and African Studies (SOAS), University of London, United Kingdom on May 15 | 2009-05-15 |
Treatment of chronic hepatitis B virus | Seminar on Viral Hepatitis for Nurses 2009 organized by Centre for Health Protection, Department of Health, Hong Kong on March 26 | 2009-03-26 |
Management of chronic hepatitis B | Infectious Disease Conference 2009 organised by Hospital Authority Infectious Disease Control Training Centre, Hospital Authority Infectious Disease Centre at Princess Margaret Hospital & Johns Hopkins University on February 21 | 2009-02-21 |
Presented at the Meet-the-expert session | BMS-sponsorship session on the topic “Short-term Treatment Goals: Reflections on HBeAg Seroconversion” during the APASL 2009, Hong Kong on February 13 | 2009-02-13 |
New approaches to monitoring HBV-DNA during hepatitis B treatment | Roche Diagnostic Satellite Symposium, 19~^th~~ Conference of the APASL, 2009, Hong Kong on February 13 | 2009-02-13 |
Treatment approach of a patient with CHB” at the Meet the Experts Forum | 2~^nd~~ St. Luke’s International Liver Conference, Manila, Philippines between January 19-20 | 2009-01-20 |
Plenary lecture on “Managing primary nonresponse/relapse to antivirals in CHB” | 2~^nd~~ St. Luke’s International Liver Conference, Manila, Philippines between January 19-20 | 2009-01-19 |
HBV: Who to treat, when to treat and with what drug? | Symposium of Infection Control Association of Macao on November 28 | 2008-11-28 |
HBV: Who to treat, when to treat and with what drug? | GSK CHB Evening Syposium in Hong Kong on November 21 | 2008-11-21 |
Treatment end points: translating clinical trials into clinical practice | BMS sponsored satellite symposium in the Second Ditan International Conference on Infectiuos Diseases, Beijing, China on November 15 | 2008-11-15 |
Management of Suboptimal Response | CME-certified AASLD satellite symposium entitled, “HBV Providers’ Choice in “PRIME” Time: Addressing Issues of Patient Populations, Resistance, Individualized Treatment, Management, and Efficacy” in San Francisco, CA, USA on 2 November | 2008-11-02 |
Modern endpoints for HBV treatment | Postgraduate Course, 59th Annual Meeting of the American Association for the Study of Liver Diseases in San Francisco, CA, USA October 31 - November 4 | 2008-10-31 |
HBV: who to treat, when to treat and what drug? | Postgraduate Course of the 50th Anniversary of International Association for the Study of the Liver in tandem with the 59th Annual Meeting of the American Association for the Study of Liver Diseases in San Francisco, CA, USA between October 31 to November 2 | 2008-10-31 |
Screening of HCC in China and managing high risk patient groups | 6th Australian Viral Hepatitis Conference, Brisbane, Australia between October 20-22 | 2008-10-20 |
What is the best treatment endpoint for CHB management? | 3rd B Foucs Conference organized by the Chinese Infectious Disease Assocation in Beijing, China between Octoebr 18-19 | 2008-10-18 |
Management of hepatitis B: the champion’s approach in 2008 (State-of-the-Art Lecture) | Conference “Winning Concepts of Gastroenterology and Hepatology: the View of International Experts’ jointly organized by Johns Hopkins University School of Medicine and Renji Hospital, Shanghai Jiao Tong University School of Medicine in Shanghai, China | 2008-08-04 |
Comparison of two new guidelines of treatment for chronic hepatitis B from the United States | Keynote speaker at the plenary session on “Antiviral treatment strategy, focusing on treatment indication, treatment duration, end point, etc.” in the China National Conference on Hepatitis and Liver Disease | 2008-07-07 |
How can we achieve the best end point of CHB management? | Guangdong Medical Association of Hepatology in Guangzhou, China | 2008-07-05 |
Treatment paradigms in CHB | Singapore Physicians Symposium in Singapore | 2008-06-06 |
CHB natural history and treatment paradigm | Baraclude (Entecavir) Speaker Training Program ‘Evolving treatment paradigms in CHB’ | 2008-06-06 |
Advances in the CHB treatment strategy | Hongkong-shenzhen communication conference on CHB management in Shenzhen, China | 2008-05-24 |
Management of hepatitis B infection | British Infection Society Trainees’ Day, London, United Kingdom on May 14 | 2008-05-14 |
Optimal screening programme for HCC in endemic areas” at the session ‘Plenary I – Early diagnosis of prevalent cancers: screening amd imaging | Inaugural William and Elizabeth Davies Foundation Trust International Meeting jointly organized by the Royal College of Physicians and Surgeons of Glasgow and the Hong Kong College of Physicians in Hong Kong | 2008-05-10 |
96 weeks of Entecavir (ETV) re-treatment of HBeAg(-) ETV patients who previously discontinued treatment | 18th Conference of the Asian Pacific Association for the Study of the Liver (APASL) in Seoul, Korea | 2008-03-25 |
Discovery and prospects for new HBV therapy | 18th Conference of the Asian Pacific Association for the Study of the Liver (APASL) in Seoul, Korea | 2008-03-24 |
Emerging therapy for chronic hepatitis B” at the Postgraduate Course 2: Overview of Hepatitis B | 18th Conference of the Asian Pacific Association for the Study of the Liver (APASL) in Seoul, Korea | 2008-03-24 |
Emerging therapy for chronic hepatitis B | International Symposium on Hepatology 2007 in Hong Kong | 2007-11-23 |
Treatment goals: can CHB be cured? | APASL Single Topic Conference on Innovative of CHB Management in Pattaya, Thailand | 2007-11-22 |
Emerging therapy for chronic hepatitis B | APASL Single Topic Conference on Innovative of CHB Management in Pattaya, Thailand | 2007-11-22 |
CHB treatment guidelines: do they advance or represent roadblocks to appropriate treatment of patients? | CME-accredited satellite symposium ‘Chronic HBV infection: Navigating the road to successful patient outcomes’ during the 58th Annual Meeting of the American Association for the Study of Liver Diseases at Boston, USA | 2007-11-04 |
Update on chronic hepatitis B | 9~^th~~ Joint Annual Scientific Meeting of The Hong Kong Society of Gastroenterology, The Hong Kong Society of Digestive Endoscopy, Hong Kong Society for Coloproctology, Hong Kong Association for the Study of Liver Diseases and The Hong Kong Society of Gastrointestinal Motility | 2007-09-08 |
Review of telbivudine GLOBE trial (year 1 and year 2) and using baseline predictive results to optimize results in HBV pos & neg patients | Hong Kong Association for the Study of Liver Diseases symposium on ‘Bridges to new ways on HBV care’ | 2007-09-03 |
Update on hepatitis B | Medical Grand Round of Princess Margaret Hospital, Hong Kong | 2007-08-22 |
介紹各類型肝炎 | 全港十八區巡迴健康展覧及講座 「與我何肝」之丙型肝炎 organized by the Hong Kong Liver Foundation, Hong Kong (public talk) | 2007-08-17 |
Chronic hepatitis B infection: (a) critical approach to treatment guidelines; (b) the telbivudine (GLOBE) trial | Round Table Discussion Meeting on ‘The latest approach for the management of chronic hepatitis B’ organized by the Infection Control Committee of Macau Government Hospital, Macau | 2007-08-11 |
Current and future strategies in improving treatment outcomes In chronic hepatitis B | Inaugural Conference of the Hepatology Society of Philippines held in Manila, Philippines | 2007-08-04 |
Two-Year Results from the GLOBE Trial: Telbivudine (LdT) vs Lamivudine | Novartis (Sebivo) Launch Symposium of Hepatology Society of Philippines held in Manila, Philippines | 2007-08-04 |
Mapping the Future – Resistance Forum | Educational Forum, Asia Pacific Resistance Advisory Board Meeting in Melbourne, Australia | 2007-07-18 |
Currently licensed agents and their comparison | BMS sponsored satellite symposium in in the China National Conference on Hepatitis and Liver Disease | 2007-07-07 |
Who to treat? - A critical ceview of two new treatment guidelines from the States. Comparison of current treatment options | BMS Satellite Symposium at the National Hepatology Congress in Instanbul, Turkey between June 7-10 | 2007-06-08 |
Faculty Presenter and Expert Panelist | DDW CME Satellite Symposium entitled "Challenge the HBV Experts" which was held on May 20, 2007 during the Digestive Disease Week (DDW) in Washington, DC, USA between May 19-22 | 2007-05-19 |
Update on chronic hepatitis B treatment | BMS sponsored CME Symposium entitled "The Importance of Viral Load and Hepatitis B Treatment Update" organized by The Hong Kong Medical Association in Hong Kong on May 10 | 2007-05-10 |
Hepatitis B virus treatment update | Novartis Standalone Meeting organized by Novartis India Limited in Hyderbad, India on May 6 | 2007-05-06 |
Update on chronic hepatitis B treatment and guideline | Round Table Discussion organized by Britsol-Myers Squibb (Hong Kong) Ltd. in Hong Kong on April 26 | 2007-04-26 |
Presentation on New aspect on anti-virals | Round-table Discussion on: New Aspects on Anti-viral Agents for Chronic Hepatitis B organized by Novartis Korea Limited in Seoul, Korea on April 23-24 | 2007-04-23 |
HBV treatment update | Post Graduate Course of the 17~^th~~ Asian Pacific Association for the Study of the Liver (APASL) Conference "Viral Hepatitis and Hepatocellular Carcinoma in Asia" in Kyoto, Japan between March 27-30 | 2007-03-27 |
Entecavir & Nucs | HBV Day of the 17~^th~~ Asian Pacific Association for the Study of the Liver (APASL) Conference "Viral Hepatitis and Hepatocellular Carcinoma in Asia" in Kyoto, Japan between March 27-30 | 2007-03-27 |
Lamivudine/Adefovir/Entecavir | HBV Day of the 17~^th~~ Asian Pacific Association for the Study of the Liver (APASL) Conference "Viral Hepatitis and Hepatocellular Carcinoma in Asia" in Kyoto, Japan between March 27-30 | 2007-03-27 |
The importance of monitoring the disease | Hepatitis B Awareness Campaign HK 2007 organized by The Hong Kong Liver Foundation in Hong Kong on March 18 | 2007-03-18 |
Hepatology | 50~^th~~ Anniversary Scientific Meeting of The Society of Physicians of Hong Kong on March 18 | 2007-03-18 |
Two-year results from the GLOBE trial: telbivudine (LdT) vs lamivudine | Telbivudine Indonesian Launch Meeting held in Jarkarta, Indonesia on February 3 | 2007-02-03 |
Clinical applicability of the latest AASLD / APASL guidelines in the Asian population | Telbivudine Indonesian Launch Meeting held in Jarkarta, Indonesia on February 3 | 2007-02-03 |
Role of HBV genotypes in managing CHB among Asians | First St. Luke's International Liver Conference held in Manila, Philippines between January 15-16 | 2007-01-15 |
Clinical applicability of the latest AASLD / APASL guidelines in the Asian population | First St. Luke's International Liver Conference held in Manila, Philippines between January 15-16 | 2007-01-15 |
Viral resistance to nucleos(t)ide analogues effect of HBV DNA suppression | KASL Autumn Symposium held in Korea on November 22 | 2006-11-22 |
Viral resistance to nucleos(t)ide analogues and the effect of HBV DNA suppression | International Symposium on Hepatology 2006 organized by The Hong Kong Association for the Study of Liver Diseases held in Hong Kong between November 3-4 | 2006-11-03 |
Understanding HBV disease: viral load and disease progression | 57~^th~~ AASLD Annual Meeting: CME-Certified Satellite Symposum "Focus on the Virus: A new paradigm for the management and treatment of HBV" organized by Clinical Care Options, LLC in Boston, USA on October 30 | 2006-10-30 |
Two-year results from the GLOBE Trial in patients with hepatitis B: greater clinical and antiviral efficacy for telbivudine (LdT) vs lamivudine | 57~^th~~ AASLD Annual Meeting held in Boston, USA between October 27 – 31 | 2006-10-30 |
Rising to the challenge in the management of chronic hepatitis B | BMS Satellite Symposium DDW-Japan 2006 held in Sapporo, Japan on October 12 | 2006-10-12 |
Rising to the challenge in the management of chronic hepatitis B | HKASLD Scientific Symposium Programme – Raising a New Standard in Chronic Hepatitis B Management, held in Hong Kong on September 28 | 2006-09-28 |
Patient case | BMS Entecavir European Launch Meeting "On the Road to Optimizing HBV Treatment with Baraclude" held in Paris, France between September 22-23 | 2006-09-22 |
Treatment guidelines: are we missing patients at risk? | BMS Chronic Hepatitis B Updates "Evidence for Action – Hope for Hepatitis B" held in Trengganu, Malaysia on September 2 | 2006-09-02 |
Viral load and disease progression | BMS Chronic Hepatitis B Updates”Evidence for Action – Hope for Hepatitis B”held in Trengganu, Malaysia on September 2 | 2006-09-02 |
Understanding viral resistance: impact and importance on treatment | BMS Chronic Hepatitis B Updates "Evidence for Action – Hope for Hepatitis B" held in Trengganu, Malaysia on September 2 | 2006-09-02 |
The Natural History and Treatment of Chronic Hepatitis B: Consensus and Controversies | 'FOCUS on Hepatitis B' meeting in Shenzhen on August 26 | 2006-08-26 |
The Natural History of Chronic Hepatitis B | Plenary Session entitled 'HBV and HDV: Virology, Immunology, Natural History, Treatment' in the 12th International Symposium on Viral Hepatitis and Liver Disease, Paris, July 4 | 2006-07-04 |
New and Future Treatment Options for Chronic Hepatitis B | 11th Hong Kong Medical Forum, Department of Medicine on June 4 | 2006-06-04 |
Duration of Therapy — How Long Do You Treat? | BMS Satellite Symposium entitled 'Expert Perspectives: Refining the HBV Treatment Paradigm' in the Digestive Disease Week, LA, USA between May 20-25 | 2006-05-20 |
The Natural History and Treatment of Chronic Hepatitis B: the Asian Perspective | BMS Scientific Meeting 'Viral Load and the Management of Chronic Hepatitis B: What can we learn from Cohort Studies' in the 41st Annual Meeting of the European Association for the Study of the Liver held in Vienna, Austria, April 28 | 2006-04-28 |
Oral presentation on "Phase II, Multi-centre, Dose-escalating Study of LH80380 (ANA 380) in Hepatitis B Patients with Lamivudine-resistant YMDD Mutant HBV" | 41st Annual Meeting of the European Association for the Study of the Liver held in Vienna, Austria, April 27 | 2006-04-27 |
Relevance of Viral Load in the Management of Chronic Hepatitis B | BMS 'Meet-the-Experts Sessions' in the 41st Annual Meeting of the European Association for the Study of the Liver held in Vienna, Austria, April 26-30 | 2006-04-26 |
Management of Chronic Hepatitis B: Consensum and Controversies | BMS Symposium on 'Time to Act in Hepatitis B: Earlier Intervention for a Progressive Disease' held in Malaysia, April 20 | 2006-04-20 |
Treatment of Chronic Viral Hepatitis B & C | Seminar on Viral Hepatitis for Nurses 2006 held by Centre for Health Protection, Department of Health, Hong Kong on April 8 | 2006-04-08 |
Management of Chronic Hepatitis B: Consensus and Controversies | BMS Symposium 'Time, Triggers and Treatment: Turning the Tide of Hepatitis B' in the Shanghai-Hong Kong International Liver Congress, Shanghai, China, March 26 | 2006-03-26 |
Current and Future Antivirals in the Management of CHB | Satellite Symosium (II) of the 2006 Spring Convention of Gastroenterological Society of Taiwan, March 17 | 2006-03-17 |
HBV Genotypes: Implications in Management | Scientific Session 'Clinical Symposium 9: Viral Genotyping' at the 16th Asian Pacific Association for the Study of the Liver (APASL) in Manila, Philippines, March 7 | 2006-03-07 |
Oral presentation on "Telbivudine Displays Consistent Antiviral Efficacy Across Patients Subgroups for the Treatment of Chronic Hepatitis B: Results from the Globe Study" | 16th Asian Pacific Association for the Study of the Liver (APASL) in Manila, Philippines, March 6 | 2006-03-06 |
Predictors of Viral Resistance: Conclusions from RCTs | Scientific Session 'Clinical Symposium 4: Chronic Hepatitis B: Viral Resistance' at the 16th Asian Pacific Association for the Study of the Liver (APASL) in Manila, Philippines, March 6 | 2006-03-06 |
Management of Chronic Hepatitis B: Consensus and Controversies | BMS Satellite symposium at the 16th Asian Pacific Association for the Study of the Liver (APASL) in Manila, Philippines, March 6 | 2006-03-06 |
Role of antiviral treatment for patients with hepatitis B related hepatocellular carcinoma | Molecular Biology of the Cell ISSN: 1059-1524 ; eISSN: 1939-4586 | 2006-03-01 |
Rising to the challenge in chronic hepatitis B management | BMS Symposium held under the auspices of Chatper of Gastroenterologists, College of Physicians, Singapore and Gastroenterological Society of Singapore, Singapore, March 1 | 2006-03-01 |
Entecavir, other new oral antiviral drugs and future prospects for therapy of CHB | Symposium on ‘Current Management of Chronic Hepatitis B’ at the 14th Indian Association for the Study of the Liver Conference (INASL 2006) held in Nagpur, India, February 26 | 2006-02-26 |
The natural history and treatment of chronic hepatitis B: Consensus and controversies | BMS Chronic Hepatitis B Global Advisory Board held in Madrid, Spain, February 10 | 2006-02-10 |
Hepatitis B Virus Subtypes, Genotypes and Replicative States: What Do They Mean? | State-of-the-Art-Lecture at the 7th Annual Scientific Meeting of the Centre for the Study of Liver Disease, The University of Hong Kong, Hong Kong, January 21 | 2006-01-21 |
A phase III comparative trial of telbivudine (LdT) vs. lamivudine for chronic hepatitis B: First-year results from the large international GLOBE trial | Idenix/Novartis "Telbivudine Phase III GLOBE – US HBV Experts Forum" held in Hawaii, USA, December 15 | 2005-12-15 |
The Natural History and Treatment of Chronic Hepatitis B: Consensus and Controversies | International Symposium on Hepatology 2005 organized by HKASLD in Hong Kong, November 25-26 | 2005-11-25 |
Maximal Early HBV Suppression is Predictive of Optimal Virologic and Clinical Efficacy in Nucleoside-Treated Hepatitis B Patients: Scientific Observations from A Large Multinational Trial (the GLOBE Study) | 56th AASLD Annual Meeting in San Francisco, USA, November 11-15 | 2005-11-15 |
Telbivudine (LdT) vs. Lamivudine for Chronic Hepatitis B: First-Year Results from the International Phase III GLOBE Trial | 56th AASLD Annual Meeting in San Francisco, USA, November 11-15 | 2005-11-15 |
The Natural History and Treatment of Chronic Hepatitis B: Consensus and Controversies | Leon Schiff State-of-the-Art Lecture at the 56th AASLD Annual Meeting in San Francisco, USA, November 11-15 | 2005-11-15 |
New and Future Treatment Options for Chronic Hepatitis B | 56th AASLD Annual Meeting in San Francisco, USA, November 11-15 | 2005-11-15 |
HBV genotypes | Colloquium of Bristol-Myers Squibb Infectious Diseases Colloquium in New York, USA, October 20 | 2005-10-20 |
Treatment of HBeAg-positive chronic hepatitis B patients | 6th International Meeting on Therapy in Liver Diseases, Barcelona, Spain, September 28-30 | 2005-09-28 |
HBV subtypes, genotypes and replicative states: What do they mean? | State-of-the-Art (IASL) lecture in the World Congress of Gastroenterology 2005 Meeting, Montreal, Canada, September 12-14 | 2005-09-12 |
Management of hepatitis B & update on entecavir global studies | Seminar organized by Associação Chinesa dos Profissionalis de Medicina de Macau, August 30 | 2005-08-30 |
Invited lecture on "Cost Effectiveness of Screening for Hepatocellular Carcinoma" | Symposium for Medical & Health Professionals Liver Cancer: Prevention & Cure in 21st Century on "Screening and Prevention of Liver Cancer" organized by The Hong Kong Anti-Cancer Society | 2005-08-27 |
Screening and Prevention of Liver Cancer | International Journal of Psychology ISSN: 0020-7594 ; eISSN: 1464-066X | 2005-08-27 |
BMS Satellite Symposium 'Time to ACT in Hepatitis B – Earlier intervention for a progressive diseases' on "A new treatment option for chronic hepatitis B infection: An update on entecavir" | 15th Asian Pacific Association for the Study of the Liver, Bali, Indonesia, August 18-21 | 2005-08-18 |
Debate I: "Entecavir as first line treatment for CHB: Pro & Cons" | 15th Asian Pacific Association for the Study of the Liver, Bali, Indonesia, August 18-21 | 2005-08-18 |
"Treatment of chronic hepatitis B : New antiviral agents" and "Management of Chronic Hepatitis B and Update on Entecavir Global Studies" | 2005 Entecavir National Train-the-Trainer Seminar in Jiu Zhai Gou, China, July 29 | 2005-07-29 |
Treatment of Chronic Hepatitis B | 5th Shanghai International Conference on Gastroenterology, Shanghai, China, July 8 | 2005-07-08 |
Chemoprophylaxis for Hepatocellulcar Carcinoma | 5th Shanghai International Conference on Gastroenterology, Shanghai, China, July 7 | 2005-07-07 |
Management of Chronic Hepatitis B and Update on Entecaivr | BMS Satellite Symposium, KASL Spring Congress 2005 | 2005-05-28 |
Management of Chronic Hepatitis B and Update on Entecavir Global Studies | BMS Satellite Symposium at the 12th National Congress for Viral Hepatitis and Liver Diseases | 2005-05-14 |
Treatment of HBV Infection | the seminar on viral hepatitis for nurses 2005 organized by Department of Health, Hong Kong | 2005-04-23 |
Chronic B Hepatitis, Management and Research Updated | Continuous Medical Education in Internal Medicine 2004/2005 organized by Serviços de Saúde of Governo da Região Administrativa Especial de Macau, Macau | 2005-03-05 |
New Antiviral Agents for Chronic Hepatitis B” at the Meet-the-Expert session | Asian Pacific Association for the Study Liver -2004 conference | 2004-12-11 |
Adefovir as First Line Nucleoside Analogue for Chronic Hepatitis B: PRO | Asian Pacific Association for the Study Liver -2004 Conference | 2004-12-11 |
Management of Asymptomatic HBsAg-positive Subjects with Normal ALT and HBV DNA >100000 copies/ml | Asian Pacific Association for the Study Liver -2004 Conference | 2004-12-11 |
Review/Critique of studies on natural history of hepatitis B | AASLD-APASL Research Workshop on Epidemiology and Natural History of Liver Diseases in Asia | 2004-12-11 |
Emerging Therapeutic Problems in Chronic Hepatitis B – A New Treatment Option for HBeAg-negative Patients | Asian Pacific Association for the Study Liver -2004 conference | 2004-12-11 |
Liver cancer | Cancer Prevention and Health – Expo 2004 organised by Lions Club of Hong Kong | 2004-12-05 |
Liver cirrhosis and liver cancer | International Forum on Liver Fibrosis 2004 | 2004-11-25 |
“New Insights in Antiviral Treatment of Chronic Hepatitis B” at the Continuing Education Seminar | “Lamivudine, Adefovir and New Antiviral Agents” organized by Pharmacy Central Continuing Education Committee | 2004-11-17 |
Chemoprophylaxis for Hepatocellular Carcinoma | 4th International Meeting on HCC: East & Western Experiences | 2004-11-15 |
Cirrhosis and carcinoma: what are the predictors of progression?” at the BMS supported, CME-accredited symposium “Building new strategies in chronic hepatitis B | 55th Annual Meeting of the American Association for the Study of Liver Disease | 2004-10-29 |
New Insights in Antiviral Treatment of Chronic Hepatitis B | Asian Pacific Digestive Week | 2004-10-05 |
Advances in Treatment of Hepatiits B Infection | Alimentary Disease Weekend | 2004-09-19 |
Interpreting Abnormal Laboratory Findings: Liver Function | 9th Hong Kong Medical Forum | 2004-07-18 |
Update on the Nature History of Chronic Hepatitis B | 9th Hong Kong Medical Forum | 2004-07-18 |
Invited speaker on "New Insights in antiviral Treatment of Chronic Hepatitis B" at the "Advances in Medicine 2004" | Faculty of Medicine, The Chinese University of Hong Kong in Hong Kong Convention and Exhibition Centre | 2004-06-20 |
Lecture on the "Treatment of HBV infection" | Seminar on Viral Hepatitis for Nurses 2004 in the Lecture Theatre of Hong Kong Central Library | 2004-05-15 |
Invited lecture on "Use of Nucleoside Analogues in Chronic Hepatitis B Virus Infection" | Hong Kong-Shanghai International Liver Congress 2004, Hong Kong | 2004-02-16 |
Lecture on "Entecavir is Superior to Lamivudine in Reducing Hepatitis B Virus DNA in Patients with Chronic Hepatitis B Infection" | Hong Kong-Shanghai International Liver Congress 2004, Hong Kong | 2004-02-16 |
Talk on "Do Nucleoside/Nucleotide Analogues Meet the Management Challenge?" | GSK Symposium at the Hong Kong-Shanghai International Liver Congress 2004, Hong Kong | 2004-02-16 |
Guest speaker on "Overview of New Antiviral Agents for Chronic Hepatitis B | First International Liver Symposium for Evolving Issue in Asia-Pacific Countries on "Antiviral Therapy for Hepatitis B; Past, Present and Future" held in Seoul, Korea | 2004-02-13 |
Lecture on "What Should be the Endpoint of Chronic Hepatitis B Treatment" | Plenary Session II, the 9th Medical Research Conference, Medical Science Group, The University of Hong Kong | 2004-02-08 |
Talk on "L-thymidine and Related Compounds" | Next Generation of HBV Inhibitors Session of the "HEP DART 2003: Frontiers in Drug Development for Viral Hepatitis" in Hawaii, USA | 2003-12-16 |
Talk on "Chronic Hepatitis B – Durability of Response to Therapy and Therapeutic End-points" | International Symposium on Hepatology 2003 organised by The Hong Kong Association for the Study of Liver Diseases | 2003-11-29 |
Invited lecture on "Update on Non A Hepatitis" | CME Luncheon Meeting of The Private Practising Paediatricians Study Group | 2003-11-14 |
Invited lecture on "Current Antiviral Therapy For Hepatitis B: The Perspective From Asia" | CME Satellite Symposium "Optmizing the Management of Hepatitis B 2003" sponsored by Ochsner Clinic Foundation, L.L.C. and jointly supported by Idenix Pharmaceuticals Inc and Novartis Pharmaceucials Corporation in Boston, Massachusetts, USA | 2003-10-27 |
Invited lecture on "Clinical challenge 4: Managing Expectations from Therapy: What Is The Duration of Response And When Should Therapy Be Stopped?" | CME-accredited Symposium "Unanswered Questions in the Treatment of Chronic Hepatitis B" jointly organized by CME Consultants, Inc. and Bristol-Myers Squibb Company in Boston, Massachusetts, USA. | 2003-10-26 |
Talk on "Newer Developments of the Hepatitis B Virus - Precore Mutations and HBV Genotype" | Colloquium of Bristol-Myers Squibb Company in New York, USA | 2003-10-16 |
Talk on "Treatment of Chronic Hepatitis B" | Hong Kong College of Family Physicians | 2003-08-02 |
Invited lecture on "Treatment of Chronic Hepatitis B" | Hong Kong College of Family Physicians | 2003-08-02 |
Newer Developments of the Hepatitis B Virus Precore Mutations and ccc HBV DNA | Bristol-Myers Squibb Infectious Diseases Selection Committee Meeting at Cap Cod, USA, 19-22 June 2003 | 2003-06-20 |
Invited lecture on "International Phase IIB Trial of LdT, and LdT plus Lamivudine, in patients with chronic hepatitis B" at the Workshop "Clinical Experience with New Antivirals against HBV" | International Symposium on Viral Hepatitis & Liver Disease, Sydney, Austrialia | 2003-04-09 |
A joint talk with Professor Geoffrey W. McCaughan on "Controversies in HBV Management: To Treat or Not to Treat?" | Mini-Symposium at the 3rd triennial International Society for Viral Hepatitis and Liver Diseases in Sydney, Australia | 2003-04-06 |
Liver Biospy vs Surrogate Markers in Clinical Trial Settings | BMS symposium at the International Symposium on Viral Hepatitis & Liver Disease, Sydney, Austrialia on 6 April 2003 | 2003-04-06 |
The Natural History of HBV: Precore mutants and ccc HBV DNA | Invited by the Gastroenterological Society of Singapore on 20 March 2003 | 2003-03-20 |
Advances in the Treatment of HBV Infection | 19th Annual Congress of Pakistan Society of Gastroenterology and GI Endoscopy between 28 February – 2 March 2003 | 2003-03-01 |
Hepatocellular Carcinoma | 19th Annual Congress of Pakistan Society of Gastroenterology and GI Endoscopy between 28 February – 2 March 2003 | 2003-02-28 |
Management of Chronic Hepatitis B | 19th Annual Congress of Pakistan Society of Gastroenterology and GI Endoscopy between 28 February – 2 March 2003 | 2003-02-28 |
Treatment of Chronic Hepatitis B : Past, Present and Future | 19th Annual Congress of Pakistan Society of Gastroenterology and GI Endoscopy between 28 February – 2 March 2003 | 2003-02-28 |
Current Topics on the Treatment of Chronic Hepatitis B | 'GlaxoSmithKline Luncheon Seminar' at the 6th General Meeting of the Japanese Society of Hepatology in DDW-Japan Yokohama, Japan, October 25, 2002 | 2002-10-25 |
Two Clinical Applications of the Line Probe Assay | Organised by GlaxoSmithKline Limited at the Hong Kong Academy of Medicine Jockey Club Building, Hong Kong, 24 September. | 2002-09-24 |
Advances in the Treatment of Chronic Hepatitis B with Nucleoside Analogues | National Symposium on Diagnosis & Treatment of Liver Diseases, Lianjiang, Guangdong, China | 2002-07-07 |
Cost effectiveness of screening for hepatocellular carcinoma | "Symposium in Medical Sciences - 21st Century Health Care in Hong Kong: A New Era", Faculty of Medicine, The University of Hong Kong, Hong Kong, 2 June 2002 | 2002-06-02 |
(1) Advances in the treatment of HBV infection (2) Natural history of chronic hepatitis B (3) Acceptance of liver biopsies | 2nd Indian Ocean Conference on Viral Hepatitis organised by Fremantle Hospital & Health Services, Perth, Australia, 25 May 2002 | 2002-05-25 |
Lamivudine - 5 years data | Symposium on "Chronic Hepatitis B Management: Sharing Best Practice" organised by the Hong Kong Association for the Study of Liver Diseases, 9 May 2002, Hong Kong | 2002-05-09 |
Clinical outcomes with long-term lamivudine therapy | 37th Annual Meeting of the European Association for the Study of the Liver "The Spectrum of Chronic Hepatitis B: Managing the Diversity of Patients", 20 April 2002, Madrid, Spain | 2002-04-20 |
Treatment of HBV infection | Seminar on "Current treatments on hepatitis B and recent development for anti-HBV therapy" organised by LG Chem Investment Ltd | 2002-03-22 |
Therapeutics advances in chronic hepatitis B: update on lamivudine therapy | 10th International Congress on Infectious Diseases "Hepatiitis Disease Management - Integrating Prevention, Diagnostics and Therapeutics, 11-14 March 2002, Singapore | 2002-03-11 |
Treatment of HBV infection | 2nd Asian Pacific Digestive Week Gastroenterology Postgraduate Course "Viral Hepatitis and Gastric Cancer in the Molecular Age" of the World Congress of Gastroenterology, 24 February - 1 March 2002, Bankgok, Thailand | 2002-02-25 |
Clinical application of the line probe assay, Innogenetics | HBV Distributor Training "INNO LiPA HBV Genotyping, Precore and Resistance Testing" organised by Innogenetics Biotechnology for Healthcare, 24 February 2002, Bangkok, Thailand | 2002-02-24 |
Treatment of chronic hepatitis B virus infection | Academic Seminar organised by the Associacao Chinesa dos Profissionais de Medicina de Macau, 20 January 2002, Macau | 2002-01-20 |
L-nucleosides | HEP DART 2001, Frontiers in Drug Development for Viral Hepatitis, 16-20 December 2001, Maui, Hawaii, USA | 2001-12-17 |
The treatment of chronic hepatitis B | 11th Annual Bristol-Myers Squibb Award for Distinguished Achievement in Infectious Diseases Colloquium, 15 November 2001, Newport, USA | 2001-11-15 |
HCV - assessing the risk of cirrhosis and hepatocellular carcinoma | 4th Scientific Congress of Academy of Insurance Medicine of Asia, 4-7 November 2001, Ho Chi Minh City, Vietnam | 2001-11-04 |
Recent research on the treatment of chronic hepatitis B | 6th Hong Kong Medical Forum, Department of Medicine, Faculty of Medicine, The University of Hong Kong, 7-8 July 2001, Hong Kong Convention & Exhibition Centre, Hong Kong | 2001-07-08 |
Treatment of Chronic Hepatiits B | Bristol-Myers Squibb Company Infectious Disease Selection Committee Meeting, 21-24 June 2001, Newport, Rhode Island, USA | 2001-06-21 |
Period | Position | Journal / Conference |
---|---|---|
2016 | International Advisory Board Member | |
2014 | Editorial Board Member | Journal of Hepatitis Research |
2011 | Associate Editor | Hepatology International |
2011 | Editorial Board Member | Journal of Clinical Hepatology |
2007 | Member of the Editorial Board | Journal of Viral Hepatitis |
2007 | Member of the Editorial Board | Hepatology International |
2007 | Member of the Editorial Board | Current Hepatitis B Reports |
2007 | Member of the Editorial Advisory Board | Medical Tribune Hong Kong |
2005 - 2006 | Editor for Hepatology | Journal of Gastroenterology and Hepatology |
2006 | Editorial Board Member | The Primary Care Clinic, CMP Medica, Hong Kong |
2001 | Member of the Editorial Board | Journal of the American Society of Clinical Oncology |
2000 | Member of the Editorial Board | The Lancet Infectious Diseases |
Start Date | End Date | Position | Type | Title |
---|---|---|---|---|
1982-01-01 | 2018-12-01 | Diplomate | O | International Board of Proctology |
2020-08-01 | 2023-06-01 | Member | O | Joint Scientific Committee for Phase 1 Clinical Trials (JSC), Consortium on Harmonization of Institutional Requirements for Clinical Research (CHAIR), Hospital Authority, Hong Kong |
1982-01-01 | 2013-03-01 | Member | O | Hong Kong Society of Gastroenterology |
1982-01-01 | 2019-12-01 | Member | O | International Association for the Study of the Liver |
2013-03-01 | 1999-12-01 | Honorary Fellow | O | Hong Kong Society of Gastroenterology |
2013-04-01 | 1999-03-01 | Fellow | O | Hong Kong Society of Gastroenterology |
2014-05-01 | 2016-11-01 | Member of the Review Committee | O | American Association for the Study of Liver Diseases (AASLD) |
2009-01-01 | 2016-12-01 | Member | O | Gilead Hepatitis B Global Advisory Board |
1991-01-01 | 2021-12-01 | Examiner | O | Membership Examination, Royal College of Physician, UK |
1987-01-01 | 1999-12-01 | Member | O | Hong Kong Association for the Study of Liver Diseases |
1993-10-01 | 2021-12-01 | Member | O | Hong Kong Institution of Science |
1993-01-01 | 1999-12-01 | Founding Member | O | Hong Kong Institution of Science |
1978-01-01 | 1999-12-01 | Member | O | Asian Pacific Association for the Study of the Liver |
2013-09-01 | 2017-09-01 | Member of the External Review Committee (ERC) | O | Hong Kong Sanatorium & Hospital |
1996-01-01 | 2021-05-01 | Board Member | O | Asian-Pacific Hepatitis B Public Health Strategy Board |
2014-01-01 | 2015-07-01 | Vice-President | O | Hong Kong Hep B Free Foundation |
2016-05-01 | 2016-05-01 | Chief Examiner in Medicine | O | Examination in Professional Knowledge of the 2015 Licensing Examination (Second Sitting) |
2015-07-01 | 2021-07-01 | President | O | Hong Kong Hep B Free Foundation |
2003-01-01 | 2013-12-01 | Reviewer | O | National Medical Research Council (NMRC), Singapore |
2020-01-01 | 2022-01-01 | Advisor | O | State Key Laboratory of Liver Research (The University of Hong Kong) |
2010-10-01 | 2021-05-01 | Deputy Director | O | State Key Laboratory of Liver Research (The University of Hong Kong) |
2010-05-01 | 1999-12-01 | Chairman | O | Central Committee on Liver Diseases (CCLD), Hospital Authority, Hong Kong |
2014-11-01 | 2015-11-01 | Chief Examiner in Medicine | O | Examination in Professional Knowledge of the 2014 Licensing Examination (First Sitting) |
2018-05-01 | 2018-05-01 | Chief Examiner in Medicine | O | Examination in Professional Knowledge of the 2018 Licensing Examination (First Sitting) |
2001-01-01 | 1999-12-01 | Consultant | O | Hong Kong Liver Transplant Patients' Association |
2012-03-01 | 2013-03-01 | Member of the International Advisory Board | O | The Asian Pacific Association for the Study of the Liver |
1992-10-01 | 2021-12-01 | Member | O | Professional & General Affairs Committee, Liaison Subcommittee, Hong Kong College of Physicians |
2014-03-01 | 2016-03-01 | Member of International Advisory Board | O | 23rd Conference of the Asian Pacific Association for the Study of the Liver |
1990-01-01 | 2018-12-01 | Member | O | Scientific Working Group on Viral Hepatitis Prevention, Department of Health, Hong Kong |
2016-11-01 | 2017-11-01 | Chief Examiner in Medicine | O | Examination in Professional Knowledge of the 2017 Licensing Examination (First Sitting) |
1994-10-01 | 2021-12-01 | Member | O | Subspecialty Advisory Committee, Hong Kong College of Physicians |
1997-10-01 | 2021-05-01 | Board Member | O | Specialty Board in Gastroenterology & Hepatology of Hong Kong Region, Hong Kong College of Physicians |
1997-10-01 | 2013-12-01 | Specialty Programme Diector | O | Specialty Board in Gastroenterology & Hepatology of Hong Kong Region, Hong Kong College of Physicians |
2012-09-01 | 2013-09-01 | Member of the Organizing Committee of the State Key Lab for Liver Research (SKLLR) Symposium 2013 | O | State Key Lab for Liver Research (SKLLR) |
1986-01-01 | 1999-12-01 | Fellow Member | O | American Association for the Study of Liver Diseases |
1999-10-01 | 2016-12-01 | Member | O | Bristol-Myers Squibb Hepatitis Advisory Board |
2014-09-01 | 2016-09-01 | Member of the Organizing Committee of the State Key Lab for Liver Research (SKLLR) Symposium 2015 | O | State Key Lab for Liver Research (SKLLR) |
2013-11-01 | 2014-07-01 | Chief Examiner in Medicine for the Examination in Professional Knowledge of the 2013 Licensing Examination | O | Medical Council of Hong Kong |
2012-08-01 | 2013-05-01 | Judging Panel Member | O | Roche Young Scientist Award (RYSA) 2012/13 |
2014-09-01 | 2015-05-01 | Judging Panel Member | O | Roche Young Scientist Award (RYSA) 2014/15 |
2013-02-01 | 2014-02-01 | Chief Examiner in Medicine | O | Examination Sub-committee, Licentiate Committee, The Medical Council of Hong Kong |
2009-03-01 | 2021-03-01 | Deputy Chairman | O | Institutional Review Board of HKU/HA Hong Kong West |
2012-06-01 | 2013-06-01 | Invited Reviewer | P | General Research Fund and the Early Career Scheme for 2012-2013 exercise f the Research Grants Council (RGC), Hong Kong |